Froidevaux-Klipfel Laurence, Targa Benjamin, Cantaloube Isabelle, Ahmed-Zaïd Hayat, Poüs Christian, Baillet Anita
INSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Present address: UMR 996, "Inflammation, Chimiokines et Immunopathologie," INSERM, Université Paris-Saclay, Clamart, France.
Oncotarget. 2015 Nov 3;6(34):36063-80. doi: 10.18632/oncotarget.5373.
The mechanisms of cancer cell adaptation to the anti-microtubule agents of the taxane family are multifaceted and still poorly understood. Here, in a model of breast cancer cells which display amplified microtubule dynamics to resist Taxol®, we provide evidence that septin filaments containing high levels of SEPT9_i1 bind to microtubules in a way that requires tubulin long chain polyglutamylation. Reciprocally, septin filaments provide a scaffold for elongating and trimming polyglutamylation enzymes to finely tune the glutamate side-chain length on microtubules to an optimal level. We also demonstrate that tubulin retyrosination and/or a high level of tyrosinated tubulin is crucial to allow the interplay between septins and polyglutamylation on microtubules and that together, these modifications result in an enhanced CLIP-170 and MCAK recruitment to microtubules. Finally, the inhibition of tubulin retyrosination, septins, tubulin long chain polyglutamylation or of both CLIP-170 and MCAK allows the restoration of cell sensitivity to taxanes, providing evidence for a new integrated mechanism of resistance.
癌细胞对紫杉烷类抗微管药物的适应机制是多方面的,目前仍知之甚少。在此,在一个显示微管动力学增强以抵抗紫杉醇®的乳腺癌细胞模型中,我们提供证据表明,含有高水平SEPT9_i1的septin丝以一种需要微管蛋白长链多聚谷氨酰胺化的方式与微管结合。相反,septin丝为延长和修剪多聚谷氨酰胺化酶提供了一个支架,以将微管上的谷氨酸侧链长度精细地调节到最佳水平。我们还证明,微管蛋白再酪氨酸化和/或高水平的酪氨酸化微管蛋白对于允许septin与微管上的多聚谷氨酰胺化之间的相互作用至关重要,并且这些修饰共同导致CLIP-170和MCAK向微管的募集增强。最后,抑制微管蛋白再酪氨酸化、septin、微管蛋白长链多聚谷氨酰胺化或同时抑制CLIP-170和MCAK可恢复细胞对紫杉烷的敏感性,为一种新的综合耐药机制提供了证据。